31 research outputs found

    Gamma Oscillations in the Mouse Primary Visual Cortex as an Endophenotype of Schizophrenia

    Get PDF
    Gamma oscillations (20-50 Hz) are a robust component of brain activity associated with information processing, but are also part of the background spontaneous activity during various brain states including sleep and anesthesia. Our goal was to examine the changes in gamma oscillations that result from pharmacological and genetic manipulations of glutamatergic transmission which produce endophenotypes of schizophrenia. We recorded local field potentials (LFP) and single units through the depth of the mouse primary visual cortex in vivo and examined the alterations in gamma frequency activity under both normal and pathological conditions. Our results indicate that both in awake and anesthetized animals, baseline gamma frequency power in the LFP is increased throughout the cortical lamina, and the signal-to-noise ratio of gamma oscillations produced by a visual stimulus is diminished, most notably in the superficial layers. In addition, the entrainment of single units to the local oscillations in the LFP is reduced in the supragranular (L2/3) and infragranular (L5/6) layers. This work supports the hypothesis that alterations in glutamatergic transmission result in changes to gamma oscillations in primary sensory areas and is consistent with the hypothesis that these changes are associated with disrupted sensory perception

    Results of the ANOVA analyses on all the tests.

    No full text
    <p>The table shows the results for the main, the peak value and the subgroup analysis. The main analysis was performed on all subjects for all data. The peak value analysis included only the basal values and the maximal effect before administration of flumazenil. The subgroup analysis included the subjects with peak plasma levels of clobazam before administration of flumazenil and plasma concentrations of at least 200 µg/ml during the same period (n = 8). The table shows the p values for the interaction of drug with time and for the factors drug and time. For analyses with a significant interaction, the results of the effects of the factors drug and time are not interpretable and are therefore not presented (marked as n/p).</p>*<p>: P-Values <0.05. VAS: pain intensity as assessed by the visual analog scale (0  =  no pain, 10  =  worst pain imaginable). AUC: area under the curve. DSST: digit symbol substitution test (measure of psychomotor performance). n/a: not applicable. n/p: not presented.</p

    Results of the pain tests performed.

    No full text
    <p>The data are expressed as mean (SD). Statistical significance is shown in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0043896#pone-0043896-t003" target="_blank">table 3</a>.</p><p>n/a: not applicable. AUC: area under the curve. VAS: visual analog scale for pain (range 0–10).</p

    Pharmacokinetic parameters of clobazam.

    No full text
    <p>The table reports the parameters in all volunteers and in the subgroup that included the subjects with peak plasma levels of clobazam below 180 minutes and plasma concentrations of at least 200 µg/ml during the same period (n = 8). Data are expressed as mean values (SD).</p

    Time plan of the experiment.

    No full text
    <p>Horizontal arrow: Testing time; ZZ: Resting time; EX: Medical examination, installation of the testing equipment and training measures; CT: Measures on the area of capsaicin hyperalgesia; ET: Cutaneous electrical stimulation; ED: Intramuscular electrical stimulation, pressure stimulation, cold pressor test, conditioned pain modulation and cuff algometry; BT: Psychomotor performance test; b: Blood sample.</p

    Static pinprick hyperalgesia after capsaicin.

    No full text
    <p>The area of static hyperalgesia significantly increased with the active placebo tolterodine (p<0.001), but not with clobazam and clonazepam.</p

    Overview of the results.

    No full text
    <p>The table synthetizes the findings of the the main, peak value and subgroup analysis. The statistical significance for “factors” drug and interaction of drug with time is presented. Significance for “factor” time alone is omitted.</p

    Center of Pressure parameters during quiet standing.

    No full text
    <p>Mean (± SEM) center of pressure parameters from the quiet standing posture during four sensory condition: eyes open and firm surface (EO), eyes closed and firm surface (EC), eyes open and soft surface (EO-soft) and eyes closed and soft surface (EC-soft). The CoP Standard Deviation (SD) and speed in medial–lateral (ML) and anterior–posterior (AP) directions are presented for the less severe (KL score 1 and 2), severe (KL score >2) groups. Significant increases in body sway during EC-soft compared with EO-soft condition are indicated (*, interaction between <i>surface</i> and <i>vision</i>; NK: <i>P<</i>0.01). Significant increase in body sway during EC compare EO condition is marked with “<sup>#</sup>” (interaction between <i>surface</i> and <i>vision</i>; NK: <i>P = </i>0.02). Significant higher values during EC-soft compared with all other conditions (<sup>¥</sup>, Interaction between <i>surface</i> and <i>vision</i>; NK: <i>P<0.01</i></p
    corecore